Clinical Trial Update: Ceftolozane/Tazobactam Versus Meropenem for Febrile Neutropenia on Patients Colonized With or at Risk for Infection With Extended Spectrum Beta Lactamase - Producing Pathogens [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing ceftolozane/tazobactam to meropenem for febrile neutropenia in patients colonized with or at risk for ESBL-producing pathogens;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Febrile Neutropenia

Drugs mentioned

• Ceftolozane/Tazobactam (ceftolozane/tazobactam)
• Meropenem (Meropenem)

Snippet

Sponsor: Beneficência Portuguesa de São Paulo | Conditions: Febrile Neutropenia | Phase 4 | Status: RECRUITING